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Abstract
Background: Transcriptomic techniques are now being applied in ecotoxicology and toxicology
to measure the impact of stressors and develop understanding of mechanisms of toxicity.
Microarray technology in particular offers the potential to measure thousands of gene responses
simultaneously. However, it is important that microarrays responses should be validated, at least
initially, using real-time quantitative polymerase chain reaction (QPCR). The accurate
measurement of target gene expression requires normalisation to an invariant internal control e.g.,
total RNA or reference genes. Reference genes are preferable, as they control for variation
inherent in the cDNA synthesis and PCR. However, reference gene expression can vary between
tissues and experimental conditions, which makes it crucial to validate them prior to application.
Results: We evaluated 10 candidate reference genes for QPCR in Daphnia magna following a 24
h exposure to the non-steroidal anti-inflammatory drug (NSAID) ibuprofen (IB) at 0, 20, 40 and 80
mg IB l-1. Six of the 10 candidates appeared suitable for use as reference genes. As a robust
approach, we used a combination normalisation factor (NF), calculated using the geNorm
application, based on the geometric mean of three selected reference genes: glyceraldehyde-3-
phosphate dehydrogenase, ubiquitin conjugating enzyme and actin. The effects of normalisation are
illustrated using as target gene leukotriene B4 12-hydroxydehydrogenase (Ltb4dh), which was up-
regulated following 24 h exposure to 63–81 mg IB l-1.
Conclusions: As anticipated, use of the NF clarified the response of Ltb4dh in daphnids exposed
to sublethal levels of ibuprofen. Our findings emphasise the importance in toxicogenomics of
finding and applying invariant internal QPCR control(s) relevant to the study conditions.
Background
Toxicogenomics is an evolving discipline investigating
stressor impact at the genome level [1]. Microarrays are
state-of-the-art tools for global gene expression profiling
of the response of an organism in a particular biological
context. However, expression levels of key genes respond-
ing on the microarray need to be validated [2]. The pre-
ferred technique of validation is by real-time quantitative
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is a fairly reliable technique, amplification can vary
depending on factors such as RNA integrity, reverse tran-
scriptase (RT) efficiencies, sample-to-sample variations in
amplification efficiency, and variation in cDNA sample
loading. Using the same sample sizes, assessing RNA
integrity and equalising RNA concentrations prior to RT
are some of the basic normalisation steps in QPCR [5].
However, normalisation to some internal control is essen-
tial for accurate QPCR to balance sample-to-sample varia-
tions within the RT and PCR reactions. Internal control is
generally achieved using reference genes, also known as
housekeeping genes.
Some of the most commonly used reference genes, such as
β-actin and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), are historical carryovers from northern blot-
ting, a "predecessor" of QPCR [5]. It is good practice to
rigorously validate the suitability of these reference genes
under the specific experimental condition to which they
are applied [5-7]. Total RNA and rRNA have also been sug-
gested as internal controls, although again differences
between tissue, individuals and experimental conditions
apply [8]. Moreover, using RNA as an internal control has
the disadvantage of not controlling for variation inherent
in the RT and PCR reactions [5]. None of these genes or
RNA products are completely invariable, and thus each
needs validation before use [5-7]. A further problem of
using only one reference gene for normalisation, is that it
theoretically should have been normalised itself prior to
target gene normalisation [9]. Various methods have been
proposed to overcome these problems. One involves the
use of a normalisation factor (NF) based on the geometric
mean of multiple carefully selected reference genes. This
NF can be calculated by geNorm (see Vandesompele et al.,
2002 [10] and the geNorm website [11]) or other freely
available Excel (Microsoft) based software applications,
e.g. BestKeeper [12] (see Pfaffl et al., 2004 [9]). Vandes-
ompele et al., 2002 [10] recommend that NFs should be
estimated from a minimum of three reference genes. The
advantage of this approach is that it allows for the cumu-
lative error of the entire process from RNA extraction to
the QPCR.
Here we evaluate 10 candidate reference genes for QPCR
in Daphnia magna following a 24 h exposure to the non-
steroidal anti-inflammatory drug (NSAID) ibuprofen
(IB); 20, 40 and 80 mg IB l-1. This concentration range rep-
resents a sublethal exposure based on our earlier work
showing that the effect concentration needed to immobi-
lise 50% (EC50) of the exposed individuals was 107.7 mg
IB l-1 following 48 h [13]. The tested candidate reference
genes were chosen to cover a range of gene ontologies
(Table 1, Methods), but mostly representing what may be
considered as classical reference genes such as actin and
GAPDH [6].
We use the geNorm algorithm [10] to estimate the varia-
bility of the reference genes, and to discover an optimal
normalisation factor (NF), based on the geometric mean
of three of them. geNorm estimates reference gene varia-
bility by calculating an expression level ratio for any two
candidate reference genes. The variation between the
expression ratios is then used as an inverse measure to
estimate the variability of the analysed reference genes
(please see Methods or Vandesompele et al., (2002) [10]
for further information). The approach is illustrated using
as target gene the D. magna ortholog of leukotriene B4 12-
hydroxydehydrogenase (Ltb4dh), which was identified as
being up-regulated in a suppressive subtractive hybridisa-
tion following 24 h exposure to 63–81 mg IB l-1 [13].
Ltb4dh is of special interest because NSAIDs are known to
inhibit the mammalian biosynthesis of various eicosa-
noids (e.g. prostaglandins, epoxyeicosatrienoic acids and
leukotriene) that play important regulatory and signalling
functions, for instance regulation of ion flux [14,15]. As
anticipated, use of the NF clarified the response of Ltb4dh
to ibuprofen.
Results
Water chemistry and quantification of ibuprofen
The chemical parameters pH and conductivity remained
stable throughout the exposure, ranging between 7.8–7.9
and 422–452 µS cm-1, respectively. Water temperatures
ranged from 20.8 to 21.0°C. Ibuprofen-sodium increased
measured pH by approximately 9% and conductivity by
approximately 7% in the highest treatment (80 mg IB l-1)
compared with the control (data not shown).
Quantification of IB revealed that nominal concentrations
were within ± 10% of the measured concentration; except
for 20 mg IB l-1 replicate three that was 10.6% lower than
the nominal (data not shown). No mortality was
observed in D. magna in any of the treatments following
exposure.
Relative expression and variability of candidate reference 
genes
Relative gene expression was estimated using DART-PCR
(see Methods). There was a significant (p < 0.05) down-
regulation of Atb and Cyp at 80 mg IB l-1 compared with
the control (Table 2). The eight candidate reference genes
unaffected by the IB treatment were analysed by geNorm
(see Methods) ranking the least variable genes as; UBC =
GAPDH <Act <WARS <SDH <TBP <18S <28S (Table 2).
Subsequently, geNorm was applied to estimate seven nor-
malisation factors,NF2 to NF8, based on the geometric
mean of the relative expression of the included reference
genes. The geNorm algorithm allocates the two least vari-Page 2 of 8
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Table 1: Candidate reference genes and target gene investigated
Gene name Symbol GenBank 
accession no.
wFleaBase 
EST no.
Gene Ontologya Forward primer (5'-3') Reverse primer (5'-3') Amplicon 
size (bp)
Actin Act AJ292554 Structural constituent of cytoskeleton (F) 
GO:0005200
CCA CAC TGT CCC CAT 
TTA TGA A
CGC GAC CAG CCA AAT 
CC
71
Alpha-tubulin Atb WFes0007807 Microtubule (C) GO:0005874 TGG AGG TGG TGA CGA 
CT
CCA AGT CGA CAA AGA 
CAG CA
89
Cyclophilin Cyp WFes0012034 Protein folding (P) GO:0006457 GAC TTT CCA CCA GTG 
CCA TT
AAC TTT CCA TCG CAT 
CAT CC
78
Glyceraldehyde-3- phosphate 
dehydrogenase
GAPDH AJ292555 Glycolysis (P) GO:0006096 GGC AAG CTA GTT GTC 
AAT GG
TAT TCA GCT CCA GCA 
GTT CC
89
Succinate dehydrogenase SDH WFes0009191 Tricarboxylic acid cycle (P) GO:0006099 TGC CAT TTA GTC GCA 
CTC AG
GTG AGC TTG TCC TCC 
TTT GC
89
TATA-box binding protein TBP WFes0002485 Transcription initiation (P) GO:0006367 GCA GGG AAG TTT AGT 
TTC TGG A
TGG TAT GCA CAG GAG 
CAA AG
88
Tryptophanyl- tRNA synthetase WARS WFes0003968 Tryptophanyl-tRNA ligase activity (F) 
GO:0004830
GCA CTG TGA TCA GCT 
CTT GC
TTT CGA TTG GAG GAA 
ATT CG
82
Ubiquitin Conjugating Enzyme UBC WFes0004602 Ubiquitin-dependent protein catabolism (P) 
GO:0006511
TCA CCT GCA CTC ACC 
ATT TC
AAT CTC CGG AAC CAA 
AGG AT
90
18S ribosomal RNA 18S AF070104 Protein biosynthesis (P) GO:0006412 CGC TCT GAA TCA AGG 
GTG TT
TGT CCG ACC GTG AAG 
AGA GT
77
28S ribosomal RNA 28S AF532883 Protein biosynthesis (P) GO:0006412 GAG GCG CAA TGA AAG 
TGA AG
TGT TCG AGA CGG GAT 
CA
70
Leukotriene B4 12-hydroxy- 
dehydrogenaseb
Ltb4dh DY242190 Response to toxin (P) GO:0009636 AAC CTA CAC CGA GGG 
TTT CG
TCC AAC ATT AAC GCC 
ATT AAG C
70
aSeveral of the candidate reference genes are classified within multiple biological processes (P), molecular functions (F) or associated with one or more cellular components (C). A biological 
function, accompanied by a GO number, has been listed here for each gene (for more information visit http://www.geneontology.org/).
bTarget gene also known as 15-oxoprostaglandin 13-reductase or more generally as NADP(H)-dependent alkenal/one oxidoreductase
BMC Genomics 2006, 7:175 http://www.biomedcentral.com/1471-2164/7/175able genes, here GAPDH and UBC, to NF2. Then the
sequential NF3 was based on the genes from NF2 and the
third least variable gene Act, and so on.
Variability of normalisation factors
Pairwise comparisons of sequential normalisation factors
computed by geNorm revealed a similar level of variabil-
ity between NF2 vs. NF3, NF3 vs. NF4, NF4 vs. NF5 and NF5
vs. NF6 (Fig. 1). This suggests that the use of either of these
NFs as internal control would be valid. But pairwise com-
parisons of NF6 vs. NF7 and NF7 vs. NF8, (28S (NF7) and
18S (NF8)), more than doubled the variability (Fig. 1).
Vandesompele et al., 2002 [10] recommend using as few
reference genes as feasible, but a minimum of three. Thus,
although it gave a similar variability to other combina-
tions, we chose NF3, (GAPDH, UBC and Act) since it gave
an optimal NF with a low level of variation using the low-
est possible number of reference genes.
Relative expression of reference genes following 
normalisation
There is a circular problem with normalising a target gene
with reference genes that should be normalised them-
selves prior to target gene normalisation [9]. Thus, in
addition to normalising the target gene, we also normal-
ised all 10 reference genes by NF3. Atb had the same sig-
nificant (p < 0.05) differences as prior to normalisation,
and should therefore be regarded as a target gene. None of
the other reference genes, including Cyp, were signifi-
cantly (p > 0.05) affected by IB following normalisation
(data not shown).
Relative expression of the target gene Ltb4dh following 
normalisation
Without normalisation, the target gene Ltb4dh was signif-
icantly (p < 0.05) up-regulated at 80 mg IB l-1 compared
with any of the other treatment groups having a 3.24-fold
higher expression than the control (Fig. 2). The relative
expression of Ltb4dh followed a significant (p < 0.05)
dose-dependent relationship (data not shown). Normali-
sation with NF3 produced a similar expression (Fig. 2).
The relative expression of Ltb4dh was normalised individ-
ually by each of the 10 candidate reference genes and by
NF3 to assess how their variability influenced target gene
expression. Overall, the mean fold difference in relative
expression between 80 mg IB l-1 and the control was 3.34
± 0.85 SD ranging from 1.66 (18S) to 5.15 (Atb) (Fig. 3).
Target gene expression normalised to any of the reference
genes was compared to normalisation with NF3 revealing
that there was a significant (p < 0.05) difference within the
Pairwise variation of sequential normalisation factors (NFn vs. NFn+1) stim ed by geNormFigure 1
Pairwise variation of sequential normalisation factors 
(NFn vs. NFn+1) estimated by geNorm. NF2 is based on 
the geometric mean of GAPDH and UBC; NF3 is NF2 and Act; 
NF4 is NF3 and WARS; NF5 is NF4 and SDH; NF6 is NF5 and TBP; 
NF7 is NF6 and 28S; NF8 is NF7 and 18S (gene name abbrevia-
tions as Table 1).
Table 2: Relative gene expression and variability of candidate reference genes
Relative expressiona
Gene Control 20 mg IB l-1 40 mg IB l-1 80 mg IB l-1 Gene variabilityb Amplification efficiency (E)a
Act 1.000 ± 0.078 0.963 ± 0.035 1.030 ± 0.044 1.001 ± 0.040 0.119 0.795 ± 0.066
Atb 1.000 ± 0.129 0.896 ± 0.126 0.885 ± 0.095 0.613 ± 0.045c - 1.010 ± 0.016
Cyp 1.000 ± 0.040 0.949 ± 0.103 0.900 ± 0.015 0.817 ± 0.067d - 1.038 ± 0.016
GAPDH 1.000 ± 0.093 0.914 ± 0.059 0.919 ± 0.047 0.879 ± 0.067 0.098 0.946 ± 0.029
SDH 1.000 ± 0.145 0.889 ± 0.170 0.950 ± 0.180 1.027 ± 0.026 0.160 0.992 ± 0.015
TBP 1.000 ± 0.096 0.786 ± 0.176 0.788 ± 0.153 1.038 ± 0.084 0.192 0.925 ± 0.016
WARS 1.000 ± 0.117 0.954 ± 0.098 0.906 ± 0.060 0.955 ± 0.081 0.136 0.922 ± 0.064
UBC 1.000 ± 0.040 0.995 ± 0.095 1.024 ± 0.016 0.888 ± 0.097 0.098 1.034 ± 0.013
18S 1.000 ± 0.279 2.096 ± 1.074 2.506 ± 1.640 2.204 ± 0.910 0.430 0.853 ± 0.089
28S 1.000 ± 0.261 1.247 ± 0.445 1.410 ± 0.560 1.457 ± 0.616 0.313 0.846 ± 0.020
Gene name abbreviations as Table 1.
aValues are mean ± SD (IB refers to ibuprofen). Expression levels are displayed relative to the mean control level.
bGene variability is estimated by geNorm as the variation (SD) of a given reference gene relative to the remaining reference genes (Atb and Cyp are 
not included in the analysis as they are significantly down-regulated by IB).
cHighest treatment (80 mg IB l-1) significantly different from any other treatment (p < 0.05).
dHighest treatment (80 mg IB l-1) significantly different from control (p < 0.05).Page 4 of 8
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BMC Genomics 2006, 7:175 http://www.biomedcentral.com/1471-2164/7/17580 mg IB l-1 treatment between normalisation of Ltb4dh to
Atb and Cyp respectively, and Ltb4dh normalised to NF3
(Fig. 3). Although not significant (p > 0.05), normalisa-
tion of Ltb4dh to either 18S or 28S caused a large increase
in the variation of target gene expression in any of the IB
treatments (Fig. 3). Both rRNA genes reduced significant
differences observed in Ltb4dh, with or without normali-
sation to NF3 (data not shown).
Discussion
We investigated the variability of 10 candidate reference
genes in D. magna following a 24 h exposure to IB to dis-
cover the least variable internal control(s) for QPCR nor-
malisation. A comparison of the reference genes, using the
geNorm software, ranked the least variable genes as; UBC
= GAPDH <Act <WARS <SDH <TBP <18S <28S. Atb and
Cyp were not included in the geNorm analysis as they were
down-regulated by IB. Furthermore, geNorm identified
the optimal normalisation factor as NF3 based on the geo-
metric mean expression of UBC, GAPDH and Act. This NF
was based on the lowest recommended number of refer-
ence genes with the lowest level of variation [10]. The
response to IB of an example target gene, Ltb4dh, was little
changed by application of NF3 (Fig. 2), although at the
highest concentration of IB, there was a slight increase in
the response, and a diminution of the variation between
replicates. Such reduction in the variation between repli-
cates is exactly what one hopes to achieve through nor-
malisation.
Relative gene expression of target gene Ltb4dh in Daphnia magna following a 24 h exposur  to ibuprofenFigure 2
Relative gene expression of target gene Ltb4dh in 
Daphnia magna following a 24 h exposure to ibupro-
fen. Mean relative expression (n = 3) ± SD of target gene 
Ltb4dh (amplification efficiency E = 1.060 ± 0.042) without 
normalisation (white bars) or with normalisation (black bars) 
to normalisation factor NF3 based on the geometric mean of 
Act, GAPDH and UBC (gene name abbreviations as Table 1). 
Expression levels are displayed relative to the mean control 
level. An asterisk (*) indicates a significant difference (p < 
0.05) between the highest treatment and any other treat-
ment.
Relative gene expression of target gene Ltb4dh in Daphnia magna following a 24 h exposur  to ibuprofenFigure 3
Relative gene expression of target gene Ltb4dh in 
Daphnia magna following a 24 h exposure to ibupro-
fen. Mean relative expression (n = 3) ± SD of Ltb4dh follow-
ing normalisation to 10 candidate reference genes and a 
normalisation factor (NF). Expression levels are displayed rel-
ative to the mean control level. For comparison, the normal-
ised relative expression of Ltb4dh is displayed by treatment 
group. Relative expression of Ltb4dh normalised to: Act (1); 
Atb (2); Cyp (3); GAPDH (4); SDH (5); TBP (6); WARS (7); UBC 
(8); 18S (9); 28S (10); NF3 based on the geometric mean of 
Act, GAPDH and UBC (11); and Ltb4dh without normalisation 
(12) (gene name abbreviations as Table 1). An asterisk (*) 
indicates a significant difference (p < 0.05) from Ltb4dh nor-
malised by NF3.Page 5 of 8
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exposure to IB [13]. NSAIDs are known to inhibit the bio-
synthesis of various eicosanoids that play important regu-
latory and signalling functions, e.g. regulation of ion flux.
In mammals, Ltb4dh is involved in the metabolism of leu-
kotriene B4 an eicosanoid that is formed in the lipoxygen-
ase pathway [15]. There is evidence of eicosanoid
pathways in invertebrates being similar to the mamma-
lian pathways [16]. Further experimentation, involving a
global expression profile based on cDNA microarrays, is
underway to support this hypothesis and reveal the over-
all molecular stress response of D. magna to IB. To our
knowledge, this is one of the first genomic studies to look
at the impact of a NSAID on an aquatic invertebrate. The
only non-mammalian studies are on yeast Saccharomyces
cerevisiae [17], a Drosophila cell line [18] and Bacillus meg-
aterium [19].
Following normalisation to NF3 it transpired that Atb,
assayed as a candidate reference gene, was affected by IB,
and so should be regarded as an IB target gene. In a review
on the molecular mechanism of NSAIDs in mammals,
Tarnawski and Jones, 2003 [20] reveal that it is likely that
NSAIDs exert many inhibitory effects, one of which is the
inhibition of cell division. The observed suppression of
Atb following exposure to IB could be linked to this, since
alpha-tubulin helps form microtubules that are involved
in cell division, cell structure, and transportation of vesi-
cles and organelles.
Of the remaining candidate reference genes, Act, GAPDH,
UBC, WARS, SDH and TBP had a constant expression fol-
lowing exposure to IB. But although, GAPDH and UBC
were the most stable reference genes they both had a
weakly significant (p < 0.10) linear trend of down-regula-
tion. Thus, relying solely on either of these two reference
genes for normalisation could obscure the output.
Using reference genes as an internal control in QPCR is
currently the recommended approach [5]. However,
Bustin and Nolan, 2004 [21] advocate the introduction of
more standard analysis and reporting procedures in
QPCR similar to the MIAME guidelines [22] established
for microarray technology. In union with other authors
[5,10,21,23] we would like to recommend some basic
applications for QPCR: (i) apply a dissociation curve in
every QPCR, and omit any samples diverging from the
curve; (ii) use a minimum of two non-template controls
(NTCs) in every QPCR, and omit any samples having a
cycle threshold (Ct) value close to or higher than the mean
NTC Ct-value; (iii) avoid inter-assay comparison if possi-
ble, as it is more appropriate to duplicate the samples in
one QPCR than using triplicates of each sample, but hav-
ing to run two QPCRs (S.N. Peirson, personal communi-
cation); (iv) use a NF based on a minimum of three
validated reference genes for target gene normalisation
[10]; (v) integrating the DART-PCR approach [23], which
verifies sample-to-sample variations in amplification effi-
ciency with a normalisation factor software package, e.g.
geNorm [10], creates a powerful tool for analysing relative
gene expression of target genes.
Conclusions
Investigators engaging in toxicogenomic research using
invertebrates, or vertebrate cell lines, exposed to NSAIDs
may be able to apply our findings directly under similar
experimental conditions, e.g. acute exposure. However,
we strongly recommend validating reference genes prior
to commencing target gene expression profiling under
experimental conditions different than those described
herein. Our findings stress the importance of performing
fundamental research, by validating the most invariant
internal QPCR control(s) of a particular experimental
condition, prior to investigating the expression of target
genes examined by QPCR only, or as QPCR validation of
microarray data.
Methods
Test species
Daphnia magna Straus (Clone Type 5 – IRCHA), originally
obtained from the Water Research Centre (WRc), Med-
menham, UK, were investigated. For further information
on culturing conditions of D. magna please see Hooper et
al., 2006 [24].
Experimental design and analytical chemistry
The experimental design consisted of three replicates of a
control and three treatments with ibuprofen-sodium
(Sigma-Aldrich, CAS no. 31121-93-4) containing 20, 40
and 80 mg IB l-1, respectively. Each replicate consisted of
100 third brood neonates (< 24 h old) placed in a 1000
ml glass beaker containing one litre of reconstituted fresh-
water with or without the addition of IB. Neonates were
exposed to IB for 24 h under the same conditions as stock
cultures (see Hooper et al., 2006 [24]), but without feed-
ing. To quantify IB, 1.5 ml was sampled from each repli-
cate at 0 h and 24 h and stored at -20°C. Subsequently,
the free base concentration of IB was measured at 217 nm
by UV-spectrophotometry using an Ultrospec3000 (Bio-
chrom) after the method of Pascoe et al., 2003 [25]. Con-
ductivity, pH and water temperature were checked at the
beginning and at the end of the exposure to verify stable
water chemistry.
Tissue preparation, RNA extraction and reverse 
transcription
Following exposure, the neonates were immediately
placed in 0.2 ml of RNAlater® (Ambion) and stored at -
80°C. Subsequently, total RNA was extracted using the
RNeasy Mini kit with on-column DNase treatment (Qia-Page 6 of 8
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manufacturer's instructions. RNA concentrations were
determined by spectrophotometry using GeneQuant Pro
(Biochrom). The integrity of the RNA was verified by 1%
agarose gel electrophoresis. Four micrograms of DNase-
treated total RNA was reverse transcribed with
Oligo(dT)12–18 primers (Invitrogen) using the Omniscript
Reverse Transcriptase kit (Qiagen) following the manufac-
turer's instructions. Once synthesised, cDNA was diluted
10-fold resulting in total RNA concentrations of 10 ng/µl
and stored at -20°C.
Real-time quantitative PCR
Ten expressed sequence tags (ESTs) were obtained from
the NCBI website [26] and the Daphnia Genomics Consor-
tium website [27] (see Colbourne et al., 2005 [28]). ESTs
were verified by BLASTN and BLASTX analysis [26]. Prim-
ers were designed using Primer3 [29], and synthesised by
MWG. The investigated ESTs, accession numbers, primer
sequences and gene ontology are shown in Table 1.
QPCR was conducted on the GeneAmp 5700 Sequence
Detection System (SDS) (Applied Biosystems) using
ABsolute™ QPCR SYBR® Green ROX (500 nM) mix
(ABgene). Each reaction was run in triplicate and con-
tained 2.5 µl of cDNA template (equivalent to 25 ng total
RNA) along with 900 nM primers in a final volume of 25
µl. Cycling parameters were 95°C for 15 min to activate
the DNA polymerase, then 40 cycles of 95°C for 15 s and
60°C for 1 min. Melting curves were performed by using
dissociation curve SDS software version 1.3 (Applied Bio-
systems) to verify that only a single product with no
primer-dimers were amplified.
Data analysis and statistics
Following QPCR, the raw data was exported to an Excel
workbook (Microsoft), entitled Data Analysis for Real-
Time PCR (DART-PCR) [23]. This programmed workbook
enables calculation of threshold cycles and amplification
efficiencies for every sample. Differences in amplification
efficiency were assessed using one-way analysis of vari-
ance (ANOVA), based upon the null hypotheses: (i) that
amplification efficiency is comparable within sample
groups (outlier detection) and (ii) that amplification effi-
ciency is comparable between sample groups (amplifica-
tion equivalence) [23]. Outliers identified by DART-PCR
and samples diverging from the dissociation curve were
omitted prior to further analysis.
Differences in relative expression were assessed on log-
transformed data using ANOVA and Tukey's honestly sig-
nificant difference (HSD) for post hoc comparisons.
Equality of variance was tested using Levene's test. The rel-
ative expression of the reference genes calculated by
DART-PCR was exported as an Excel workbook (Micro-
soft) to geNorm version 3.4 [10]. The "geNorm" algo-
rithm is based on the proposition that, in any set of assays,
the expression levels of suitable reference genes should be
perfectly correlated. However, because of technical diffi-
culties in assessing correlation in circumstances when
there is little variation, a modified procedure is adopted as
follows [10]. First, the ratio of expression levels is calcu-
lated for any two candidate reference genes. Assuming
that the expression ratios should not vary between assays,
the variation between the expression ratios is used as an
inverse measure, here referred to as gene variability, of the
adequacy of the reference genes to be used for normalisa-
tion. Thus, the lower the variation, the better the reference
genes. Variation is here measured as standard deviation.
Given a set of assays that covers the treatments of interest,
this procedure can be used to identify the best two refer-
ence genes from all possible pairs of reference genes avail-
able to the experimenter. A normalisation factor (NF2) is
then produced for these two genes, calculated as the geo-
metric mean of their expression levels. The procedure is
then extended to assess whether stepwise inclusion of
additional reference genes – producing NF3 to NFn – will
reduce the average pairwise variation between them. The
optimal number of reference genes to be included in a NF
is estimated by comparing the pairwise variation between
sequential normalisation factors [10], e.g. NF3 vs. NF4. All
statistical tests were performed in SPSS 12.0.1 for Win-
dows (SPSS, Chicago, IL, USA) applying a significant level
of 5%, except reference gene variability and NF analysis,
which was computed in geNorm version 3.4 [10].
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